Samsara Bio Capital, LLC Geron Corp Transaction History

Samsara Bio Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 18, 2021	SELL	$1.52 - $2.1 $1.86 Million - $2.57 Million	-1,224,870 Closed	0 $0
Q4 2020 Feb 17, 2021	SELL	$1.55 - $2.05 $474,637 - $627,746	-306,218 Reduced 20.0%	1,224,870 $1.95 Million
Q3 2020 Nov 16, 2020	SELL	$1.59 - $2.19 $3.75 Million - $5.17 Million	-2,359,132 Reduced 60.64%	1,531,088 $2.66 Million
Q2 2020 Aug 14, 2020	BUY	$1.05 - $2.18 $4.08 Million - $8.48 Million	3,890,220 New	3,890,220 $8.48 Million

274

491M

1.87M

690K

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $1.2B
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

Get notified when there are updates to the investment portfolio of Samsara Bio Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Samsara Bio Capital, LLC with notifications on news.